ImmunoBiota Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Latest Deal Amount
  • $25M

  • Investors
  • 2

ImmunoBiota General Information

Description

Provider of microbiome science research services intended to lessen the burden of inflammatory autoimmune diseases. The company specializes in addressing life-altering diseases such as Type 1 diabetes, hypertension microbiome, and gut problems by targeting dysfunctional microbiome metabolites, enabling patients to recover rapidly by decreasing autoimmune responses, halting insulin-producing beta-cell death, and significantly reducing blood pressure.

Contact Information

Website
www.immunobiota.com.au
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Melbourne, Victoria
  • Australia
Primary Industry
Biotechnology
Vertical(s)
HealthTech
Corporate Office
  • Melbourne, Victoria
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmunoBiota Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) $25M Upcoming Clinical Trials - Phase 1
3. Early Stage VC 25-Aug-2026 In Progress Clinical Trials - Phase 1
2. Early Stage VC 01-Oct-2023 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
To view ImmunoBiota’s complete valuation and funding history, request access »

ImmunoBiota Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
StartUp Health Venture Capital Minority
SBE Australia Accelerator/Incubator Minority
To view ImmunoBiota’s complete investors history, request access »

Ready to get started?

Request a free trial

ImmunoBiota FAQs

  • When was ImmunoBiota founded?

    ImmunoBiota was founded in 2022.

  • Where is ImmunoBiota headquartered?

    ImmunoBiota is headquartered in Melbourne, Australia.

  • What industry is ImmunoBiota in?

    ImmunoBiota’s primary industry is Biotechnology.

  • Is ImmunoBiota a private or public company?

    ImmunoBiota is a Private company.

  • What is ImmunoBiota’s current revenue?

    The current revenue for ImmunoBiota is .

  • Who are ImmunoBiota’s investors?

    StartUp Health and SBE Australia have invested in ImmunoBiota.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process